Ashish Nimgaonkar

Ashish Nimgaonkar is the current President and CEO of Glyscend Incorporated. Ashish has also previously worked as the JHU Center for Bioengineering Innovation and Design, Stanford University, Stanford University Medical Center, Harvard Medical School, Beth Israel Deaconess Medical Center/Harvard Medical School, and The Johns Hopkins University School of Medicine. Ashish has been working in the medical field since 2003 and has been involved in a variety of different roles. Ashish is a highly educated individual, with aPostdoctoral Fellowship from the Children's Hospital Informatics Program and degrees from both Stanford University and Harvard Medical School. Ashish Nimgaonkar is a well-respected figure in the medical community and has made significant contributions to the field of medicine over the course of their career.

Ashish Nimgaonkar holds a Master of Science from Harvard University in the field of Division of Health Sciences and Technology, a Master of Technology from the Indian Institute of Technology in Biomedical Engineering, and an MD from Osmania University.

Some individuals on their team include Thomas Jozefiak - Chief Scientific Officer, Kevin Colbert - Senior Director, Operations & Strategy, and Mark Fineman - Chief Development Officer.